At the 2022 Fall Clinical Dermatology Conference, 5 practitioners share their best tips for treating their patients
Pigmentary disorders of the skin can be the cause of significant psychological distress in affected patients.
In this week’s Pointers with Dr Portela, the 208SkinDoc gives his skin discoloration treatment tips.
At the SDPA 2022 Annual Summer Dermatology Conference, a session on both common and rare dermatological disorders.
Ruxolitinib cream 1.5% may soon be the first FDA-approved treatment for repigmentation of vitiligo. Experts share what dermatologists need to know regarding efficacy, safety, and cost of this topical drug.
The skincare manufacturer and distributer announced that it has received patents for hair growth and melasma.
VisualDX uses diverse imagery to help increase knowledge of disease manifestations in a range of skin types.
In a presentation at the current AAD annual meeting, experts discussed differential diagnoses and clinical presentations in birthmarks and hamartomas.
Investigator Loren Krueger, MD, urges dermatologists to recognize and correct disparities in clinical decision-making, particularly regarding skin cancer.